Intracellular stability of tyrosine hydroxylase. Phosphorylation and proteasomal digestion of the enzyme.

Advances in Pharmacology

Volumn 68, Issue , 2013, Pages 3-11

  Nakashima, Akira ^a   Kaneko, Yoko S ^a   Kodani, Yu ^a   Mori, Keiji ^a   Nagasaki, Hiroshi ^a   Nagatsu, Toshiharu ^a   Ota, Akira ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

14 3 3 Protein; Intracellular stability; Phosphorylation; Proteasomal digestion; Tyrosine hydroxylase

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CATECHOLAMINE SYNTHESIS; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STABILITY; ENZYME SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

14-3-3 PROTEIN; INTRACELLULAR STABILITY; PHOSPHORYLATION; PROTEASOMAL DIGESTION; TYROSINE HYDROXYLASE;

ANIMALS; CATECHOLAMINES; HUMANS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; TYROSINE 3-MONOOXYGENASE;

EID: 84884325273     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/B978-0-12-411512-5.00001-4     Document Type: Chapter

References (20)

1. Bevilaqua L.R., Graham M.E., Dunkley P.R., von Nagy-Felsobuki E.I., Dickson P.W. Phosphorylation of Ser19 alters the conformation of tyrosine hydroxylase to increase the rate of phosphorylation of Ser40. Journal of Biological Chemistry 2001, 276:40411-40416.
2. Døskeland A.P., Flatmark T. Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. European Journal of Biochemistry 2002, 269:1561-1569.
3. Dunkley P.R., Bobrovskaya L., Graham M.E., von Nagy-Felsobuki E.I., Dickson P.W. Tyrosine hydroxylase phosphorylation: Regulation and consequences. Journal of Neurochemistry 2004, 91:1025-1043.
4. Haycock J.W., Wakade A.R. Activation and multiple-site phosphorylation of tyrosine hydroxylase in perfused rat adrenal glands. Journal of Neurochemistry 1992, 58:57-64.
5. Iida Y., Sawabe K., Kojima M., Oguro K., Nakanishi N., Hasegawa H. Proteasome-driven turnover of tryptophan hydroxylase is triggered by phosphorylation in RBL2H3 cells, a serotonin producing mast cell line. European Journal of Biochemistry 2002, 269:4780-4788.
6. Itagaki C., Isobe T., Taoka M., Natsume T., Nomura N., Horigome T., et al. Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins. Biochemistry 1999, 38:15673-15680.
7. Kim K.S., Kim C.H., Chung S., Moon J.I., Hong S., Kim K.S. Dynamic regulation of tyrosine hydroxylase gene expression by key fate-determining transcription factors during dopaminergic neuronal development in vivo and in vitro 2012, Abstract.
8. Kojima M., Oguro K., Sawabe K., Iida Y., Ikeda R., Yamashita A., et al. Rapid turnover of tryptophan hydroxylase is driven by proteasomes in RBL2H3 cells, a serotonin producing mast cell line. Journal of Biochemistry 2000, 127:121-127.
9. Lew J.Y., Garcia-Espana A., Lee K.Y., Carr K.D., Goldstein M., Haycock J.W., et al. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity. Molecular Pharmacology 1999, 55:202-209.
10. Lopez Verrilli M.A., Pirola C.J., Pascual M.M., Dominici F.P., Turyn D., Gironacci M.M. Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway. Journal of Neurochemistry 2009, 109:326-335.
11. McNaught K.S., Jackson T., JnoBaptiste R., Kapustin A., Olanow C.W. Proteasomal dysfunction in sporadic Parkinson's disease. Neurology 2006, 66:S37-S49.
12. Moy L.Y., Tsai L.H. Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability. Journal of Biological Chemistry 2004, 279:54487-55493.
13. Murphy K.L., Zhang X., Gainetdinov R.R., Beaulieu J.M., Caron M.G. A regulatory domain in the N terminus of tryptophan hydroxylase 2 controls enzyme expression. Journal of Biological Chemistry 2008, 283:13216-13224.
14. Nakashima A., Hayashi N., Kaneko Y.S., Mori K., Egusa H., Nagatsu T., et al. Deletion of N-terminus of human tyrosine hydroxylase type 1 enhances stability of the enzyme in AtT-20 cells. Journal of Neuroscience Research 2005, 81:110-120.
15. Nakashima A., Mori K., Kaneko Y.S., Hayashi N., Nagatsu T., Ota A. Phosphorylation of the N-terminal portion of tyrosine hydroxylase triggers proteasomal digestion of the enzyme. Biochemical and Biophysical Research Communications 2011, 407:343-347.
16. Obsilova V., Nedbalkova E., Silhan J., Boura E., Herman P., Vecer J., et al. The 14-3-3 protein affects the conformation of the regulatory domain of human tyrosine hydroxylase. Biochemistry 2008, 47:1768-1777.
17. Sato S., Chiba T., Sakata E., Kato K., Mizuno Y., Hattori N., et al. 14-3-3η is a novel regulator of parkin ubiquitin ligase. EMBO Journal 2006, 25:211-221.
18. Shi X., Habecker B.A. gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2. Journal of Neurochemistry 2012, 120:239-247.
19. Sutherland C., Alterio J., Campbell D.G., Le Bourdlles B., Mallet J., Haavik J., et al. Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. European Journal of Biochemistry 1993, 217:715-722.
20. Xu J., Kao S.Y., Lee F.J., Song W., Jin L.W., Yankner B.A. Dopamine-dependent neurotoxicity of alpha-synuclein: A mechanism for selective neurodegeneration in Parkinson disease. Nature Medicine 2002, 8:600-606.